title: Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the US.
authors.affiliation: Division of Child Health, Leicester University Medical School, Leicester LE1 5WW, United Kingdom. david.field@uhl-tr.nhs.uk
authors.forename: David
authors.initials: D
authors.lastname: Field
authors.forename: Charles
authors.initials: C
authors.lastname: Normand
authors.forename: Diana
authors.initials: D
authors.lastname: Elbourne
mesh_terms: D003362:Cost-Benefit Analysis; D015199:Extracorporeal Membrane Oxygenation / Q000191:economics*; D006801:Humans; D000860:Hypoxia / Q000191:economics* / Q000628:therapy*; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000191:economics* / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000191:economics* / Q000628:therapy*; D014665:Vasodilator Agents / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D009569:Nitric Oxide